What Does Wall Street Think About Clarivate Plc (CLVT)?

Clarivate Plc (NYSE:CLVT) is one of the best cheap stocks under $10 to buy now. Clarivate Plc (NYSE:CLVT) reported its fiscal Q3 2025 results on October 29, with revenues for the quarter reaching $623.1 million, compared to total revenues of $622.2 million in fiscal Q3 2024.

Clarivate Plc (CLVT): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025

However, total revenues for the nine months of 2025 were $1.838 billion, compared to total revenues of $1.893 billion in the prior year period. This drop was primarily due to inorganic divestitures and disposals. However, organic revenues in nine months of 2025 grew 0.2%, primarily attributed to a 0.6% increase in organic recurring revenues. These trends were, however, partially offset by lower organic transactional revenues.

Clarivate Plc (NYSE:CLVT) revised its revenue outlook for the full year 2025 upward, highlighting increased transactional book sales before the planned June 2026 disposal, along with the favorable effect of a weaker US dollar.

Following the earnings release, Goldman Sachs lowered the price target on Clarivate Plc (NYSE:CLVT) to $4.20 from $4.80 on October 31, keeping a buy rating on the shares. However, William Blair analyst Andrew Nicholas maintained a neutral stance on the stock on October 30, giving it a Hold rating.

While Clarivate Plc (NYSE:CLVT) reported fiscal Q3 revenue that surpassed expectations due to higher-than-expected transactional revenues in the government and academic sectors, the growth stemmed from lower-margin sales, causing only modest improvement in EPS and adjusted EBITDA.

In addition, while management lifted the full-year revenue guidance due to favorable conditions, the overall growth outlook presents a mixed picture, with subscription growth and recurring revenue slightly underperforming expectations.

Clarivate Plc (NYSE:CLVT) provides global information, workflow solutions, and analytics. The company operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H).

While we acknowledge the potential of CLVT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CLVT and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.